David Turkaly
Stock Analyst at JMP Securities
(2.23)
# 2,655
Out of 4,877 analysts
141
Total ratings
40.31%
Success rate
-3.64%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $11.14 | - | 2 | Jun 6, 2025 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $59.02 | - | 3 | May 27, 2025 | |
| HAE Haemonetics | Reiterates: Market Outperform | $100 | $74.61 | +34.03% | 12 | May 20, 2025 | |
| STE STERIS | Maintains: Market Outperform | $265 → $280 | $240.22 | +16.56% | 18 | May 16, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $35 → $25 | $12.27 | +103.75% | 15 | May 9, 2025 | |
| ENOV Enovis | Maintains: Market Outperform | $62 → $55 | $31.36 | +75.38% | 2 | May 9, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $140 → $125 | $91.21 | +37.05% | 14 | May 7, 2025 | |
| CRWD CrowdStrike Holdings | Maintains: Market Outperform | $400 → $500 | $509.31 | -1.83% | 1 | May 5, 2025 | |
| SYK Stryker | Reiterates: Market Perform | n/a | $395.63 | - | 3 | May 5, 2025 | |
| TFX Teleflex | Reiterates: Market Perform | n/a | $118.36 | - | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $12 → $7 | $1.94 | +260.82% | 6 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $50 | $21.48 | +132.77% | 10 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $26 | $10.85 | +139.63% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $18.82 | +70.03% | 7 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $16 | $8.69 | +84.12% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $112 | $81.86 | +36.82% | 8 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $2.25 | - | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $7 → $3 | $3.49 | -14.04% | 7 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $4 | $3.81 | +4.99% | 4 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $9.23 | -45.83% | 1 | Oct 6, 2017 |
Orthofix Medical
Jun 6, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $11.14
Upside: -
Globus Medical
May 27, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $59.02
Upside: -
Haemonetics
May 20, 2025
Reiterates: Market Outperform
Price Target: $100
Current: $74.61
Upside: +34.03%
STERIS
May 16, 2025
Maintains: Market Outperform
Price Target: $265 → $280
Current: $240.22
Upside: +16.56%
Integra LifeSciences Holdings
May 9, 2025
Maintains: Market Outperform
Price Target: $35 → $25
Current: $12.27
Upside: +103.75%
Enovis
May 9, 2025
Maintains: Market Outperform
Price Target: $62 → $55
Current: $31.36
Upside: +75.38%
Zimmer Biomet Holdings
May 7, 2025
Maintains: Market Outperform
Price Target: $140 → $125
Current: $91.21
Upside: +37.05%
CrowdStrike Holdings
May 5, 2025
Maintains: Market Outperform
Price Target: $400 → $500
Current: $509.31
Upside: -1.83%
Stryker
May 5, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $395.63
Upside: -
Teleflex
Apr 2, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $118.36
Upside: -
Mar 21, 2025
Maintains: Market Outperform
Price Target: $12 → $7
Current: $1.94
Upside: +260.82%
Mar 21, 2025
Reiterates: Market Outperform
Price Target: $50
Current: $21.48
Upside: +132.77%
Mar 5, 2025
Reiterates: Market Outperform
Price Target: $26
Current: $10.85
Upside: +139.63%
Feb 25, 2025
Reiterates: Market Outperform
Price Target: $32
Current: $18.82
Upside: +70.03%
Jan 29, 2025
Reiterates: Market Outperform
Price Target: $16
Current: $8.69
Upside: +84.12%
Jan 14, 2025
Reiterates: Market Outperform
Price Target: $112
Current: $81.86
Upside: +36.82%
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $2.25
Upside: -
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $3.49
Upside: -14.04%
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $3.81
Upside: +4.99%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $9.23
Upside: -45.83%